Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?
TR Lim Centre for Liver Research and NIHR Biomedical Research Unit in Liver Disease, University of Birmingham and Liver and Hepatobiliary Unit, Queen Elizabeth Hospital Birmingham, UK Abstract: Metabolic syndrome is prevalent in patients with hepatitis C virus (HCV) infection. Given the pandemic s...
Saved in:
Main Author: | Lim TR |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/02779ece64b04fa19406d21e15f85d6b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents
by: Kamal SM
Published: (2014) -
How far are we from the “Treat all” era of antiviral therapy for chronic hepatitis B
by: DING Yang
Published: (2021) -
Antiviral therapy for chronic hepatitis B in the indeterminate phase is urgent
by: JIANG Jun
Published: (2021) -
Patients with chronic hepatitis B virus infection in the indeterminate phase may benefit from antiviral therapy
by: XU Jinghang
Published: (2021) -
Patients in the indeterminate phase of chronic hepatitis B virus infection should receive active antiviral therapy
by: WANG Jingyue
Published: (2021)